Introduction {#Sec1}
============

In the Netherlands and Belgium, a considerable proportion of children treated with chronic dialysis have immigrant parents from non-Western European origin (non-Western). Over the last decade, the proportion of non-Western immigrants in the Netherlands has grown from 9 to 11% \[[@CR1]\]. Data on clinical management and outcomes of patients of ethnic minorities are scarce. Yet, there is a growing awareness that there are considerable healthcare disparities between immigrants and native American patients \[[@CR2], [@CR3]\]. Stronks et al. showed that in the Netherlands, the use of general practitioner care and the use of prescribed drugs has increased among non-Western adult patients as compared to adult patients from Western European (Western) origin \[[@CR4]\].

Cultural misunderstandings between doctor and patient as well as language barriers may contribute to a different approach and subsequent disparities in quality of care. For example, a Dutch study on asthma in children showed ethnicity and limited Dutch proficiency to be important risk factors for uncontrolled asthma in children \[[@CR5]\]. Disparities for patients of non-Western background may be even more important for highly complex modes of healthcare such as chronic renal replacement therapy in children, which makes great demands on the understanding and discipline of patients and caretakers.

Little is known about the management and outcomes of children of non-Western immigrant parents requiring chronic dialysis. We therefore compared the choice of initial dialysis modality, post-initial treatment, and outcomes between first- and second-generation children of non-Western origin and those from Western origin on chronic dialysis treatment.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

All children aged \< 19 years who were treated with hemodialysis (HD) or peritoneal dialysis (PD) in the Netherlands and Belgium between September 1, 2007 and May 1, 2011 were included. Data were collected as part of the RICH-Q project (Renal Insufficiency therapy in Children - Quality assessment and improvement) \[[@CR6]\]. Follow-up data were available until May 1, 2011, or until transplantation, transition to adult care, or death. We obtained ethical approval from the ethical institutional review boards of all participating hospitals and written informed consent from the parents of all participants, and the participants themselves, if possible.

Survey on preferred first dialysis therapy {#Sec4}
------------------------------------------

At the start of RICH-Q in 2007 we asked one pediatric nephrologist per participating center to complete a questionnaire on treatment policies. The questionnaire was developed with input from all participating pediatric nephrologists to ensure content validity. The questionnaire included the following question: What is your preferred first mode of renal replacement therapy, if pre-emptive transplantation is not possible, in children \> 3 years old?

Data collection procedures {#Sec5}
--------------------------

Data were collected from the medical records of the patients by trained local research nurses or by the participating pediatric nephrologists. The following data were used: age, gender, primary cause of end-stage renal disease (ESRD), date of first chronic renal replacement therapy (cRRT), first cRRT modality, waiting time on dialysis, country of birth for the child and parents, race/ethnicity as reported by the parents , i.e., Caucasian, Black, Asian, or other, and the educational attainment of the parents. Primary causes of ESRD were classified into seven categories: glomerulopathy, hemolytic uremic syndrome, urinary tract malformation, dysplasia, primary interstitial nephritis, tubular necrosis, or other. The following outcomes were recorded: blood values of hemoglobin, phosphate, calcium, immunoreactive parathyroid hormone (iPTH), alkaline phosphatase, homocysteine, presence of hypertension, medication prescriptions, and presence of metabolic bone disease at inclusion of the patients from 2007 until 2011. Complications of the therapy, such as peritonitis incidence, HD infections, and hospitalizations were monitored during the 4-year study period.

Definitions {#Sec6}
-----------

Non-Western patients were defined as children of whom one or both parents were born in non-Western European countries \[[@CR1]\]. Western patients were defined as children from parents born in Western Europe. The total number of months on dialysis was defined as the period between the first day of dialysis and May 1, 2011 or the date of transplantation, the date of transition to adult care, or the date of death. For the calculation of the estimated glomerular filtration rate (eGFR), we used the updated version of the Schwartz formula: eGFR (ml/min/1.73 m^2^) = 0.413\* (height in cm) / serum creatinine in mg/dl) \[[@CR7]\]. The mean was calculated of three systolic and three diastolic blood pressure measurements at the time of inclusion. Hypertension was defined as either a systolic or diastolic blood pressure \> p95 of the Task Force Report normal values corrected for age and gender \[[@CR8]\]. Renal osteodystrophy (ROD) was diagnosed by an experienced radiologist based on a hand X-ray at the time of inclusion. We made a distinction between "incident patients", who were included within 3 months after the start of dialysis, and "prevalent patients" defined as patients who had been treated with dialysis for at least 3 months before inclusion. "Poor condition as reason to start dialysis" was defined by the pediatric nephrologists. Parental educational attainment was defined as the highest educational level as reported by the parents themselves.

Statistical analysis {#Sec7}
--------------------

Chi-square test or, in case of small expected cell counts, Fisher's exact test, was used to test comparisons of categorical variables between non-Western and Western patients. Student's*t* test and Mann--Whitney*U* test were used for continuous variables when appropriate.

Kaplan--Meier survival analysis was used to analyze waiting time on dialysis until transplantation. To investigate the association between non-Western status and number of peritonitis episodes per PD year at risk and ROD, respectively, linear and logistic regression analysis was performed. At first, only the central determinant was entered into the model (model with one determinant); possible confounders were then entered one at a time (multivariable models). If the regression coefficient of the central determinant 'non-Western status' changed \>10% after the addition of one determinant to the regression model, this added determinant was considered to be a confounder and was kept in the final model. To evaluate the change in the regression coefficient, the same population was included in the bi-variable analysis as in the multivariable analysis, i.e., excluding any subjects with missing values.

The following determinants were considered as possible confounders: the duration of dialysis before inclusion, poor condition as the reason to start dialysis, the cause of ESRD, and educational attainment of parents.

All analyses were performed using SPSS 18.0 for Windows statistical software. For the incidence rate of infection and hospitalization, the number of new episodes per patient year at risk was calculated. The incidence rate ratio (IRR) was calculated to compare non-Western and Western patients. Hospitalization was analyzed separately in children \< 4 years old, because the hospitalization rate is on average higher in young children.

Results {#Sec8}
=======

Characteristics and initial treatment {#Sec9}
-------------------------------------

We included 179 children, of whom 79 (44%) had parents from non-Western origin (Table [1](#Tab1){ref-type="table"}). In four patients (2%), only one parent was from non-Western origin; we considered these patients as 'non-Western' according to the definition of Statistics Netherlands (CBS) \[[@CR1]\].Table 1Demographics, cause of end-stage renal disease (ESRD) and initial treatment of children with immigrant parents of non-western European origin (non-Western) and children with parents of western-European origin (Western)Non-Western,*n* = 79 (44)Western,*n* = 100 (56)*p* valueMale50 (63)52 (52)0.130^a^Origin of parentsMorocco: 15Netherlands: 63-Turkey: 15Belgium: 34Surinam: 9Germany: 1Asia: 5Luxembourg: 1Dutch Antilles/Caribbean: 3United Kingdom: 1Russia: 2Africa (other): 15Middle East (other): 15Country of birthNetherlands: 37Netherlands: 63-Belgium: 13Belgium: 34United Kingdom: 2Germany: 1Morocco: 2Luxembourg: 1Turkey: 3United Kingdom: 1Surinam: 3Asia: 2Dutch Antilles/Caribbean: 2Africa (other): 6Middle East (other): 9Ethnicity-Caucasian42 (53)97 (97)Black25 (32)0Asian7 (9)0Mixed5 (6)3 (3)Primary cause of ESRD0.787^c^-Glomerulopathy18 (23)28 (28)-Hemolytic uremic syndrome4 (5)6 (6)-Urinary tract malformation15 (19)16 (16)-Dysplasia20 (26)24 (24)-Primary interstitial nephritis1 (1)4 (4)-Tubular necrosis5 (6)8 (8)Other16 (20)14 (14)Educational attainment of the parents0.007^a^-Elementary school15 (19)12 (12)+1.36-Secondary education8 (10)28 (28)+1.37-Post-secondary education missing9 (11)30 (30)+1.38-Missing47 (60)30 (30)+1.39Initial treatment of ESRD. Age at start of dialysis, years\* median (range)Total6.4 (0--17.0)6.4 (0--18.5)0.551^b^HD10.0 (0--17.0)8.3 (1.1--18.5)0.814^b^PD2.1 (0--16.6)4.9 (0--16.7)0.078^b^eGFR (ml/1.73 m^2^) at startdialysis\*7.4 (3.5--20.5)7.5 (2.4--31.5)0.687^b^"Poor condition" as reason to start dialysis24 (30)36 (36)0.429^a^First dialysis modality0.046^a^ HD41 (52)37 (37) PD38 (48)63 (63)PD modality0.241^a^CCPD/APD28 (78)55 (82)CAPD7 (19)7 (11)Missing1 (3)5 (7)Inclusion in RICH-QPrevalent patients46 (58%)63 (63%)0.516^a^Duration of dialysis before inclusion months\*^1^HD (*n* = 42)17.5 (3.8--63.4)8.2 (3.1--65.3)0.018^b^PD (*n* = 46)19.3 (4.1--77.5)10.6 (3.4--49.4)0.453^b^Data are presented as*n* (percentage); \*data are presented as median (range), ^a^Chi-square test, ^b^Mann--Whitney*U* test, ^c^Fisher's exact test, ^1^From start of dialysis until inclusion for the prevalent patients),*eGFR* estimated glomerular filtration rate Schwartz. ( Ref. 2009),*HD* hemodialysis,*PD* peritoneal dialysis, *CCPD* continuous cycling peritoneal dialysis, *CAPD* continuous ambulatory peritoneal dialysis, *APD* automated peritoneal dialysis, *RICH-Q* renal insufficiency therapy in children-quality assessment and improvement. Prevalent defined as \>3 months treated with dialysis before inclusion

We found no statistically significant differences between non-Western and Western patients with respect to primary cause of ESRD, gender, age at start of dialysis (HD or PD), eGFR at start of dialysis, poor condition as the reason to start dialysis, PD modality, or percentage of patients already treated with dialysis at the time of inclusion. Compared with Western children, non-Western children were significantly more often treated with HD as the first mode of cRRT, 37 vs. 52%, respectively (*p* = 0.046). The median duration of dialysis at the start of the RICH-Q project was 9 months longer in non-Western patients; in patients treated with HD, this difference was statistically significant (*p* = 0.018). Parents of non-Western European origin had a significantly lower level of educational attainment (Table [1](#Tab1){ref-type="table"}).

Preferred first dialysis therapy {#Sec10}
--------------------------------

Of the ten centers, six (60%) preferred PD as first dialysis treatment if pre-emptive transplantation was not possible for children \> 3 years old. In the four centers preferring HD, this preferred mode of dialysis was more often followed in non-Western children than in Western children (*p* = 0.006).

Post-initial dialysis treatment {#Sec11}
-------------------------------

Compared with Western patients, non-Western patients had a significantly longer median duration of HD, the median difference exceeding 10 months (*p* = 0.003) (Table [2](#Tab2){ref-type="table"}). No significant disparities were found between the two groups for the median duration of PD, the number of switches in therapy, medication use, or the time on hemodialysis per week (Table [2](#Tab2){ref-type="table"}). Relatively more non-Western than Western patients on HD had a Cimino fistula instead of a central venous catheter (53 vs. 33%), although this difference was not statistically significant (*p* = 0.080).Table 2Comparison of modes of dialysis and medication use between children with immigrant parents of non-western European origin (non-Western) and children with parents of western-European origin (Western)Dialysis characteristicsNon-Western,*n* = 79Western,*n* = 100*p *valueDuration and mode of dialysisTotal months on HD\*^1^16.8 (0.6--106.0)6.5 (0.1-66.2)0.003^b^Total months on PD\*^1^11.4 (0.2--88.3)13.6 (0.1--73.3)0.756^b^Duration of dialysis before first Tx\*^2^ (months)*n* = 8830.2 (5.0--99.0)15.0 (0.0--66.7)0.007^b^Number of switchesHD to PD1070.712^a^PD to HD14150.307^a^Total hours on HD per week\*12 (3-24)12 (3-24)0.670^b^Vascular access0.080^a^- Cimino fistula23 (53%)11 (33%)- Central venous catheter20 (47%)22 (67%)Medication prescriptionAnti-hypertensive drugs39 (52%)61 (61%)0.280^a^\> 2 anti-hypertensive drugs14 (25%)12 (29%)0.603^a^Erythropoietin68 (91%)92 (92%)0.790^a^Phosphate binder-Calcium based39 (52%)44 (44%)0.359^a^-Non-calcium based39 (52%)51 (51%)1.000^a^Etalpha60 (80%)81 (81%)1.000^a^Growth hormone25 (33%)33 (33%)1.000^a^Prophylactic antibiotics exit site17 (47%)22 (35%)0.242^a^Data are presented as*n* (percentage), \* data are presented as median (range), ^a^Chi-square test, ^b^Mann--Whitney*U* test, ^1^From start of dialysis until May 1, 2011 or until transplantation, transition to adult care, or death. ^2^From start of dialysis until first transplantation before May 1, 2011,*HD* hemodialysis,*PD* peritoneal dialysis,*Tx* transplantation

During the follow-up period, 88 children (33 non-Western and 55 Western) received a kidney transplant. Prior to transplantation, non-Western patients spent a significantly longer time on dialysis than Western patients, with a median of 30 months versus 15 months, respectively (*p* = 0.007) (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Time from start of dialysis to first transplantation in non-Western children compared to Western children,*p* = 0.007

Dialysis outcomes {#Sec12}
-----------------

The incidence rate of peritonitis was 1.0 per patient year at risk for non-Western and 0.41 per patient year at risk for Western patients. The incidence rates of HD exit site/tunnel infections were comparable in both groups (Table [3](#Tab3){ref-type="table"}).Table 3Comparison of the outcomes between children with immigrant parents of non-western European origin (non-Western and children with parents of western-European origin (Western) with end-stage renal diseaseNon-WesternWestern*P* valueIRR \[95%CI\]Blood values (at inclusion)*n*Median (range)*n*Median (range)Hemoglobin mmol/l-Incident306.8 (4.1--8.7)346.5 (3.6--8.2)0.174^b^-Prevalent466.9 (4.6--9.4)607.0 (3.5--9.0)0.871^b^Phosphate mmol/l-Incident301.65 (1.02--3.16)341.58 (0.82--2.96)0.527^b^-Prevalent461.68 (0.78--2.58)601.68 (0.85--2.79)0.831^b^Calcium mmol/l-Incident282.44 (1.25--3.24)332.40 (1.89--2.76)0.767^b^-Prevalent462.45 (2.00--3.09)592.43 (1.90--3.58)0.481^b^iPTH pmol/l-Incident2914.9 (0.1--159)2811.6 (0.1--121)0.534^b^-Prevalent4417.6 (0.3--158)5814.1 (0.4--176)0.570^b^Alkaline phosphatase U/l-Incident8411 (71-- 987)10233 ( 4--825)0.324^b^-Prevalent22408 (84--1,254)24201 (33--1,716)0.043^b^Homocysteine umol/l-Incident69.5 (4.2--14.2)1013.3 (5.3--30.7)0.093^b^-Prevalent1910.6 (3.0--26.0)2912.1 (6.0--113.0)0.217^b^Hypertension^1^(at inclusion)7633 (43)445 (47)0.607Renal osteodystrophy (at inclusion)X-ray hand: Moderate or severe signsTotal6522 (34)8315 (18)0.028^a^-incident226 (27)293 (11)0.150-prevalent4316 (36)5412 (22)0.120InfectionIRR \[95%CI\]Number of peritonitis episodes per patient year PD at risk341.00600.41-2.44 \[1.43--4.17\]Number of HD exit sites or tunnel infections per patient year HD at risk460.34330.45-0.75 \[0.38--1.50\]HospitalizationTotal number of hospitalizations per patient79100Year at risk2.723.71-0.73 \[0.62--0.87\]Age \< 4 years4.345.490.79 \[0.60--1.03\]Age \> 4 years2.293.120.73 \[0.59--0.91\]HD1.972.560.77 \[0.58--1.03\]PD3.343.331.00 \[0.79--1.26\]Days of hospitalization per year7388All ages18 (0--282)12 (0--196)0.427^b^\<4 years35 (7--282)22 (0--196)0.228^b^\>4 years12 (0--162)10 (0--158)0.422^b^Data are presented as*n* (percentage), \* data are presented as median (range), ^a^ Chi-square test, ^b^Mann--Whitney*U* test; *iPTH* immunoreactive parathyroid hormone, *HD* hemodialysis,*PD* peritoneal dialysis,*IRR* incidence rate ratio, 95% CI = 95% confidence interval. ^1^Hypertension was defined as systolic or diastolic blood pressures \> p95 of the Task Force Report normal values corrected for age and gender \[[@CR8]\].*Prevalent* is defined as \>3 months treated with dialysis before inclusion.*Incident* is defined as included within 3 months after start of dialysis

The hospitalization rate in children older than 4 years was lower in non-Western than in Western patients. Children treated with PD were admitted to the hospital more often than children on HD. Within the subgroups of HD and PD, treatment modalities the hospitalization rates of non-Western and Western patients did not differ significantly. The number of days of hospitalization was not significantly different between the groups either above or below the age of 4 years.

Compared to Western patients, non-Western patients had more peritonitis episodes, the mean difference \[95% CI\] being 0.58 \[0.03--1.14\] episodes per year at risk, adjusted for poor condition as the reason to start dialysis (Table [4a](#Tab4){ref-type="table"}).Table 4Results of linear regression analysis for episodes of peritonitis/PD year at risk in 94 children treated with peritoneal dialysis in all PD patients (5a) and in all patients in whom also data on the parental educational attainment was obtained (5b)4aB95% CIModel with one determinant (*n* = 94) Non-Western status0.650.09--1.21Multivariable models1. Non-Western status0.630.72--1.19- Months on PD before inclusion--0.01--0.09 -- 0.082. Non-Western status0.580.03--1.14-"Poor condition" as reason to start--0.60(--1.15) -- (--0.05)   4b  Model with one determinant (*n* = 60) Non-Western status0.930.11--1.74Multivariable models1. Non-Western status0.79--0.04 -- 1.62 -"Poor condition" as reason to start--0.55--1.32 -- 0.222. Non Western status0.72--0.13 -- 1.56 -"Poor condition" as reason to start--0.52--1.30 -- 0.27 Parental educational attainment (reference category: "post secondary" ) -Elementary school0.33--0.59 -- 1.25 -Secondary education--0.14--0.96 -- 0.67*PD* peritoneal dialysis

Signs of ROD at inclusion were present in 22 non-Western (34%) and 15 Western patients (18%) (*p* = 0.028) (Table [3](#Tab3){ref-type="table"}). ROD was present before the start of dialysis in 27% and 11% of the non-Western and Western patients, respectively. When adjusted for parental educational attainment, the OR \[95% CI\] for ROD in non-Western patients was 1.8 \[0.6--5.5\] (Table [5b](#Tab5){ref-type="table"}).Table 5Results of logistic regression analysis for renal osteodystrophy in 148 children treated with dialysis (5a) and in a subgroup of 87 patients on dialysis of whom we obtained data on educational attainment of the parents (5b)5. aOR95% CIModel with one determinant (*n* = 148) Non-Western status2.321.09--4.96Multivariable models1. Non-Western status2.251.05--4.82 Months on dialysis before diagnosed with ROD1.001.00--1.002. Non-Western status2.331.06--5.11 Cause of ESRD (reference category: "other") -Glomerulopathy0.570.19--1.76 -Hemolytic uremic syndrome0.270.03--2.57 -Urinary tract malformation0.400.10--1.59 -Dysplasia0.660.21--2.01 -Primary interstitial nephritis1.120.83--14.92 -Tubular necrosis1.550.33--7.363. Non-Western status2.461.14--5.34 "Poor condition" as reason to start2.130.97--4.63   5. bModel with one determinant (*n* = 87) Non-Western status2.41(0.85--6.80)Multivariable model1. Non-Western status1.75(0.56--5.47) Educational attainment of parents (reference category: "post-secondary" ) -Elementary school4.88(1.20--19.77) -Secondary education2.33(0.61--8.94)*ESRD* end-stage renal disease

Six children (3%) died during the follow-up period, three non-Western and three Western patients. Four children (two in each group) died of intercurrent diseases, one of Wilms' tumor, one of congenital heart disease, and two due to withdrawal of treatment because of multiple co-morbidities. Two children (one in each group) died of complications of the treatment of the underlying kidney disease, one of pulmonary hypertension, and one due to a complication of a central line.

Discussion {#Sec13}
==========

We found less favorable health outcomes and important disparities in the management of children on dialysis treatment with parents from non-Western European origin as compared to those from Western origin in the Netherlands and Belgium. We will discuss the possible reasons for these disparities and formulate areas for further research.

In both countries, non-Western patients more often received HD as the first mode of cRRT instead of PD as compared to Western children. Although kidney transplantation is considered to be the optimal mode of cRRT for children with ESRD, in most circumstances dialysis treatment as first cRRT is inevitable \[[@CR9]\]. There is no consensus on the optimal mode of dialysis treatment. Peritoneal dialysis (PD) is offered to younger children, especially under the age of 2 years or weighing less than 10 kg. Some centers recommend PD instead of HD in children because of its social advantages \[[@CR10]\]. PD permits a relatively normal lifestyle by allowing children to attend school full time with less dietary and fluid restrictions compared to HD. In addition, obtaining vascular access for HD in children can be challenging \[[@CR11]\]. In some European countries, hemodialysis (HD) is preferred for children over the age of 5 years \[[@CR12]\]. Factors that are reported to influence the choice of therapy include the age of the child (30%), parent preference (27%), distance from the unit (14%), patient preference (11%), social condition (7%), and inability to do one particular mode (6%) \[[@CR12], [@CR13]\]. In our study, 40% of the centers preferred HD for children \> 3 years old. We found that in Western children, the preferred mode of dialysis according to the center policy was less often followed than in non-Western children. If the preferred mode of dialysis was not followed in Western children, PD was chosen more often than HD. In non-Western children, HD prevailed if the preferred modality was not followed.

It is not clear whether the deviations from the center policy had merely been the physicians' or the patients' choice. It is possible that Western parents more often prefer a situation of having the child out of the hospital as much as possible, as with PD, despite the burden of home therapy, even in a situation where the physician advises differently. Physicians, on the other hand, may have been reluctant to offer a home dialysis program to some non-Western patients. The preference for HD might even be due to a more systematic physician bias in the treatment of non-Western patients. Our findings are consistent with race-associated disparities in the dialysis treatment of children in the United States. Furth et al. found more use of HD instead of PD in children of African American descent. Family, patient, and provider preferences all accounted for the difference in choice of therapy by race \[[@CR14]\]. In addition, they suggest that systematic racial bias specifically may have contributed to the difference in dialysis modality choice. The extent to which subtle or overt and systematic provider preconceptions about race have affected dialysis modality choice in the children in our study is unclear.

Financial motives may also play a role in the choice of either HD or PD. In the United States, unequal access to optimal medical care is an important cause for disparities in care. For example, Young et al. describe that pediatricians are facing the dilemma of rationing care to uninsured, undocumented children, especially for expensive life-saving care such as renal transplantation and dialysis \[[@CR15]\]. However, unlike in the United States, the social system in both the Netherlands and Belgium provides few financial incentives for choosing a certain treatment modality. Health insurance is mandatory. All insured patients pay an income-dependent contribution. In return, they receive all necessary medical and paramedical care for free, including dietary, psychological, and educational support. In the Netherlands, patients with a chronic disease can apply for a personal budget for extra help at home, depending on income and family situation. Even immigrants or refugees who are staying in the Netherlands or Belgium undocumented receive all necessary medical and paramedical care, if necessary for free \[[@CR16]\]. In 2010, the Netherlands was ranked first in a study comparing the health care systems of the US, Australia, Canada, Great Britain, Germany, and New Zealand \[[@CR17]\]. The study assessed five measures of healthcare; quality, efficiency, access to care, equity and, the ability to lead long, healthy, productive lives.

Non-Western patients spent significantly more time on dialysis prior to transplantation. The transplantation process involves a series of steps related to medical suitability, pre-transplant work-up, the possibility of a family member to donate, or movement up the waiting list for deceased donor to eventual transplantation \[[@CR18]\]. Some of these steps have been examined individually in previous studies in the United States \[[@CR19], [@CR20]\]. The study of Ozminkowski et al. showed that in the United States, blacks move up the waiting list at a slower rate than whites \[[@CR19]\]. Movement on the waiting list has been studied extensively, and appears to reflect both biological factors (e.g., HLA-based tissue typing) and non-biological factors (e.g., transplant center characteristics \[[@CR20]\]). Furth et al. reported racial disparities regarding access to the renal transplant waiting list in pediatric units in the United States \[[@CR21]\]. Whether these disparities were attributable to differences in the timing of presentation to a nephrologist, physician bias in identification of transplant candidates, or patient preferences was not clear.

The longer time on dialysis in our non-Western children could partly be explained by a different mode of transplantation. In an earlier study on the same cohort on transplantation policy and outcomes in non-Western children with end-stage renal disease, we found that non-Western patients less often received donor kidneys from a living related donor than deceased donor (DD) transplantations \[[@CR22]\], contrary to Western patients.

Non-Western patients who were treated with PD more often had peritonitis episodes than Western patients. This is remarkable given the relatively small number of non-Western patients on PD as compared to HD, which suggests a positive selection for this modality. The incidence rates of HD exit site/tunnel infections were similar in both groups, but non-Western patients more often had a Cimino fistula. This might be related to different policies followed in non-Western and Western patients with respect to vascular access. As discussed before, non-Western patients were less often scheduled for living-related donor transplantation and consequently more often prepared for deceased donor transplantation with a longer expected time on HD. This may have motivated physicians to choose for a Cimino fistula more often in non-Western patients.

The hospitalization rate was lower in non-Western patients \> 4 years than in Western patients of the same age. This might be explained by the fact that relatively more non-Western patients receive HD than Western patients. Children on HD are monitored regularly and intravenous antibiotics can be given during the HD treatment sessions, both circumstances that make admission less often necessary than in PD. Consistent with this, both non-Western and Western patients on PD were equally more often admitted than patients on HD.

We found that ROD was more prevalent in non-Western children. Nevertheless, in a multivariable analysis of a smaller subgroup without missing values, the educational attainment of the parents turned out to be a confounder of this association. Renal osteodystrophy (ROD), which is associated with a long duration of chronic kidney disease, is a major clinical problem in young adults with pediatric ESRD \[[@CR23]\]. To detect ROD, a bone biopsy remains the \'gold standard\' investigation. Its invasive nature and the need for specialized processing and interpretation limits the use of bone biopsy in clinical practice \[[@CR24]\]. Hand X-ray is not invasive and has a high specificity (92%) for the detection of ROD bone features \[[@CR25]\].

ROD was already present before the start of dialysis in six non-Western and three Western children. We have no evidence that non-Western patients were less compliant with therapy before they developed ESRD. We found no indication of non-adherence in surrogate outcome markers for prevention of ROD such as iPTH, phosphate and medication dosage of phosphate binders, and vitamin D derivates. Therefore, genetic factors influencing for instance the vitamin D status might have been involved. Prevention of ROD requires extreme discipline to strictly follow the dietary and medication regime. The combination of impaired schooling of the parents and cultural misunderstandings may have hampered compliance in some children of non-Western background. These patients might profit from a culturally tailored approach from the treatment team \[[@CR26]\].

In the Netherlands, there has been a shift in the non-Western population. Especially in children, we see a new generation from non-Western origin. They were born in the Netherlands, and are mostly the second generation of non-Western descent whose behavior differs from elderly first-generation non-Western adults.

Perhaps this might be one of the explanations for the difference between the results of the present study and those of a recent Dutch study in adult immigrants that showed increased survival for adult immigrant patients on dialysis in the Netherlands compared to native Dutch dialysis patients \[[@CR27]\]. Another explanation might be that ESRD in adult immigrant patients is due to different causes than in young patients.

A limitation of this study is the exclusion of children who had been transplanted before the start of the RICH-Q registry. The inclusion of patients in the RICH-Q project started in September of 2007. Only children that were treated with dialysis were included in the present study. Children who had been transplanted before this date were not included. This probably has resulted in an overrepresentation of children who are not suitable for (pre-emptive) transplantation, which may have resulted in a relatively large proportion of non-Western patients in this study. Therefore, the percentage of non-Western patients in this study is higher than in the general population. Another limitation is that we did not collect information on language barriers, which have been shown to impact a wide variety of health and healthcare outcomes \[[@CR28]\]. The parental educational attainment seemed to be a confounder in the development of ROD. Unfortunately, information on the educational attainment of the parents was missing in the majority of non-Western European children.

In conclusion, children with end-stage renal disease with parents of non-Western European origin more often receive HD instead of PD as first cRRT modality, and stay on dialysis longer before transplantation. These non-Western patients have less favorable outcomes, such as an increased risk for PD-associated peritonitis and renal osteodystrophy. This situation might be improved by education of treatment providers about these disparities and about the potential roles of conscious and unconscious bias, cultural misunderstandings, and language barriers.
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